Agentix Corp. (OTCMKTS:AGTX – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 9,518 shares, a growth of 52,777.8% from the October 15th total of 18 shares. Based on an average daily trading volume, of 138,200 shares, the short-interest ratio is currently 0.1 days.
Agentix Price Performance
Shares of Agentix stock remained flat at $0.03 during midday trading on Tuesday. The stock has a 50 day simple moving average of $0.03 and a 200 day simple moving average of $0.03. Agentix has a 52 week low of $0.01 and a 52 week high of $0.07.
About Agentix
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. The company offers AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases.
Further Reading
- Five stocks we like better than Agentix
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Agentix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agentix and related companies with MarketBeat.com's FREE daily email newsletter.
